Dr.Jaichandrika

Dr.Jaichandrika |Clyto Access

junior resident , kanchi kamakoti child's trust hospital, India

Poster Presentation

Expertise: Pediatric oncology, Hepatoblastoma

Biography:

Dr. Jaichandrika Completed M.B.B.S in the year 2013 from meenakshi medical college and research institute,Kanchipuram. late she started Working as resident at Apollo first medicine in paediatric department. Presently she is working as a junior resident in pediatric oncology
kanchi kamakoti child's trust hospital, India.
,

Presentation:

Title: PEDIATRIC INFLAMMATORY MYOFIBROBLASTIC TUMOURS OF LARYNX:TWO CASE REPORTS VARYING CLINICAL PRESENTATION

Abstract:

INTRODUCTION:

Inflammatory myofibroblastic tumor (IMFT) is a rare tumor of intermediate malignant potential. It may occur in a wide range of anatomical locations.One-third are found in the respiratory tract. We report two Cases with IMFT of airway at our institution.

CASE REPORT:

CASE 1: A 6yr old male child presented with hoarsness of voice.on evaluation,a polypoid nodule was noted in right vocal cord which was excised through endo laryngeal route. Histopathology was suggestive of ALK negative IMFT. He presented with recurrence after 4 months for which he underwent endolaryngeal reexcision and was started on celecoxib. He is under follow up with Celecoxib ,in remission

CASE 2: 7yrs old male child presented with cough and respiratory distress. Bronchoscopy and HRCT showed a polypoidal lesion with calcification arising from left anterior lateral wall of trachea with significant narrowing of the lesion.Biopsy of the mass confirmed inflammatory fibroblastic tumor.

DISCUSSION:

IMFT indicates a proliferation myofibroblastic growth.Surgical resection should be recommended for all lesions if not prohibited by anatomic location or morbidity.Patients should be followed up closely for recurrence .In most cases,complete surgical excision is suffice.however recurrences can be managed with chemotherapy.

CONCLUSION:

These two cases highlight the importance of multidisciplinary approach in rare tumors in difficult anatomical locations.Complete surgical excision remains the treatment of choice and chemotherapy is reserved for recurrences.
,

Related Conferences :

International Conference on Cancer Care and Cure